Related Experiment Video

Updated: Jan 21, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

22.5K

Retrieval of chronic hepatitis B patients in the Utrecht region in the Netherlands

M Dimmendaal1, P A M Kracht, S Dijkstra

  • 1Department for Infectious Disease Control, Public Health Services Utrecht region (GGDrU), Zeist, the Netherlands.

The Netherlands Journal of Medicine
|August 9, 2019
PubMed

Insights

Tracing lost to follow-up chronic hepatitis B (CHB) patients through past HBsAg tests and general practitioner collaboration can help re-engage individuals in care. This proactive approach aims to reduce the disease burden in the Netherlands.

Area of Science:

  • Hepatology
  • Public Health
  • Patient Management

Background:

  • Chronic hepatitis B (CHB) causes significant mortality in the Netherlands despite available treatments.
  • An estimated 49,000 individuals in the Netherlands have CHB, with many lost to follow-up (LFU).
  • Effective strategies are needed to re-integrate LFU CHB patients into healthcare systems.

Purpose of the Study:

  • To identify and re-engage LFU CHB patients in the Utrecht province.
  • To assess the feasibility of tracing LFU CHB patients through historical data and general practitioner (GP) involvement.

Main Methods:

  • Retrospective review of HBsAg-positive tests (2001-2015) from four Utrecht hospitals.
  • Collaboration with GPs to evaluate LFU CHB patients and gather data via questionnaires.
  • Analysis of patient characteristics and reasons for non-evaluation.

Main Results:

  • 2,242 CHB patients identified; 599 (27%) were eligible for retrieval.
  • GP response rate was 49% (292 patients).
  • 62 patients (10%) were evaluated, with 20 (3%) referred to hospital care.

Conclusions:

  • Screening past HBsAg tests is an effective method for tracing LFU CHB patients.
  • GPs demonstrated willingness to participate in patient retrieval efforts.
  • This strategy shows potential for reducing the overall burden of CHB disease.
Abstract

More Related Videos

Assessment of Vascular Function in Patients With Chronic Kidney Disease08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.7K
Retrieval of Mouse Oocytes08:42

Retrieval of Mouse Oocytes

Published on: April 28, 2007

28.5K

Related Concept Videos

Retrieval01:12

Retrieval

Retrieval is the process of getting information out of memory storage and back into conscious awareness. This ability is essential for daily tasks like brushing hair and teeth, driving to work, and performing job duties. Retrieval occurs in three ways: recall, recognition, and relearning.
Recall involves accessing information without cues, such as during an essay test, where individuals must retrieve facts and concepts from memory unaided. Another example is remembering the name of a colleague...
422
ER Retrieval Pathway01:45

ER Retrieval Pathway

In the secretory pathway, vesicles transport proteins from one cellular compartment to another in forward transport to deliver the protein to its correct location. Occasionally, misfolded proteins and incorrect proteins escape their original compartments, and a retrieval pathway is used to return the escaped proteins to their original compartment.
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
4.7K
IR Frequency Region: Fingerprint Region01:03

IR Frequency Region: Fingerprint Region

IR spectra are divided into two main regions: the diagnostic region and the fingerprint region. The diagnostic region of the spectrum lies above 1500 cm−1. The absorptions resulting from single-bond vibrations of the N–H, C–H, and O–H stretch at higher wavenumbers and appear on the left side of the spectrum. The stretching absorptions of the C≡C and C≡N occur between 2100–2300 cm−1. In contrast, those arising from stretching absorptions of the...
1.9K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
260
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.5K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.7K